Oscar Health Inc (NYSE: OSCR)’s stock price has soared by 0.40 in relation to previous closing price of 17.40. Nevertheless, the company has seen a gain of 0.40% in its stock price over the last five trading days. Zacks Investment Research reported 2024-02-28 that If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Oscar Health, Inc. (OSCR) could be a great choice. It is one of the several stocks that passed through our ‘Fast-Paced Momentum at a Bargain’ screen.
Is It Worth Investing in Oscar Health Inc (NYSE: OSCR) Right Now?
The 36-month beta value for OSCR is at 1.70. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for OSCR is 149.60M, and currently, shorts hold a 5.12% of that float. The average trading volume for OSCR on April 30, 2024 was 3.09M shares.
OSCR’s Market Performance
The stock of Oscar Health Inc (OSCR) has seen a 0.40% increase in the past week, with a 18.92% rise in the past month, and a 36.38% gain in the past quarter. The volatility ratio for the week is 5.24%, and the volatility levels for the past 30 days are at 5.95% for OSCR. The simple moving average for the past 20 days is 11.89% for OSCR’s stock, with a 76.86% simple moving average for the past 200 days.
Analysts’ Opinion of OSCR
Many brokerage firms have already submitted their reports for OSCR stocks, with Raymond James repeating the rating for OSCR by listing it as a “Outperform.” The predicted price for OSCR in the upcoming period, according to Raymond James is $20 based on the research report published on March 22, 2024 of the current year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see OSCR reach a price target of $9, previously predicting the price at $8. The rating they have provided for OSCR stocks is “Buy” according to the report published on November 02nd, 2023.
BofA Securities gave a rating of “Neutral” to OSCR, setting the target price at $8.75 in the report published on June 06th of the previous year.
OSCR Trading at 14.24% from the 50-Day Moving Average
After a stumble in the market that brought OSCR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -5.82% of loss for the given period.
Volatility was left at 5.95%, however, over the last 30 days, the volatility rate increased by 5.24%, as shares surge +25.27% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.75% lower at present.
During the last 5 trading sessions, OSCR rose by +0.29%, which changed the moving average for the period of 200-days by +122.29% in comparison to the 20-day moving average, which settled at $15.79. In addition, Oscar Health Inc saw 90.93% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OSCR starting from Blackley Richard Scott, who sale 27,043 shares at the price of $14.12 back on Mar 06 ’24. After this action, Blackley Richard Scott now owns 614,316 shares of Oscar Health Inc, valued at $381,847 using the latest closing price.
Quane Alessandrea C., the EVP, Chief Insurance Officer of Oscar Health Inc, sale 13,233 shares at $14.12 during a trade that took place back on Mar 06 ’24, which means that Quane Alessandrea C. is holding 212,850 shares at $186,850 based on the most recent closing price.
Stock Fundamentals for OSCR
Current profitability levels for the company are sitting at:
- -0.04 for the present operating margin
- 1.0 for the gross margin
The net margin for Oscar Health Inc stands at -0.05. The total capital return value is set at -0.21. Equity return is now at value -31.96, with -7.74 for asset returns.
Based on Oscar Health Inc (OSCR), the company’s capital structure generated 0.27 points at debt to capital in total, while cash flow to debt ratio is standing at -0.91. The debt to equity ratio resting at 0.37. The interest coverage ratio of the stock is -9.78.
Currently, EBITDA for the company is -235.62 million with net debt to EBITDA at 6.67. When we switch over and look at the enterprise to sales, we see a ratio of 0.33. The receivables turnover for the company is 11.86for trailing twelve months and the total asset turnover is 1.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.29.
Conclusion
In conclusion, Oscar Health Inc (OSCR) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
